Perrigo Completes Divestiture of Dermacosmetics Business
Perrigo completed the sale of its Dermacosmetics business to Karo Healthcare for €305.6 million upfront, plus up to €27 million in milestone payments. The divested unit generated approximately €120 million in net sales in 2025 and represented 5% of adjusted operating income.
Key figures
- Revenue
- 120000000
- Deal Value Usd
- 332600000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.